• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

Introduction to 2-Fluorobenzamidine (CAS No. 71204-93-8)

2-Fluorobenzamidine, with the CAS number 71204-93-8, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique chemical structure, which includes a fluorine atom and a benzamidine group, making it a valuable candidate for various applications, particularly in the development of novel therapeutic agents.

The chemical formula of 2-Fluorobenzamidine is C₇H₆F₂N₃, and it has a molecular weight of approximately 169.14 g/mol. The presence of the fluorine atom imparts unique electronic and steric properties to the molecule, which can influence its biological activity and pharmacokinetic behavior. These properties make 2-Fluorobenzamidine an attractive scaffold for the design of drugs targeting specific biological pathways.

In recent years, there has been a growing interest in the use of 2-Fluorobenzamidine as a lead compound for the development of new drugs. One of the key areas of research has been its potential as an inhibitor of specific enzymes involved in various diseases. For instance, studies have shown that 2-Fluorobenzamidine derivatives can act as potent inhibitors of serine proteases, which are implicated in a range of pathological conditions, including inflammation and cancer.

A notable study published in the Journal of Medicinal Chemistry in 2021 reported the synthesis and evaluation of a series of 2-Fluorobenzamidine-based compounds as inhibitors of human neutrophil elastase (HNE). HNE is a serine protease that plays a crucial role in chronic obstructive pulmonary disease (COPD) and cystic fibrosis. The researchers found that certain derivatives exhibited high potency and selectivity against HNE, suggesting their potential as therapeutic agents for these conditions.

Beyond its enzymatic inhibition properties, 2-Fluorobenzamidine has also shown promise in other therapeutic areas. For example, a study published in Bioorganic & Medicinal Chemistry Letters in 2020 investigated the use of 2-Fluorobenzamidine-derived compounds as antiviral agents. The results indicated that these compounds could effectively inhibit the replication of certain viruses, including influenza A virus and human immunodeficiency virus (HIV). This finding opens up new avenues for the development of antiviral therapies using this scaffold.

The pharmacokinetic properties of 2-Fluorobenzamidine-based compounds are another important aspect to consider. Research has shown that these compounds generally exhibit good oral bioavailability and favorable metabolic stability, which are essential characteristics for drug candidates. Additionally, their low toxicity profile makes them suitable for long-term use in therapeutic settings.

In terms of synthetic methods, several efficient routes have been developed for the preparation of 2-Fluorobenzamidine. One common approach involves the reaction of 2-fluorobenzoic acid with amidine hydrochloride in the presence of a coupling reagent such as 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC). This method allows for the facile synthesis of various substituted derivatives, enabling researchers to explore a wide range of structural modifications to optimize biological activity.

The future prospects for 2-Fluorobenzamidine-based compounds are promising. Ongoing research is focused on further optimizing their potency, selectivity, and pharmacokinetic properties to enhance their therapeutic potential. Additionally, there is growing interest in exploring their use in combination therapies to address complex diseases where multiple targets are involved.

In conclusion, 2-Fluorobenzamidine (CAS No. 71204-93-8) is a versatile and promising compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and favorable biological properties make it an attractive scaffold for the development of novel therapeutic agents targeting various diseases. As research continues to advance, it is likely that new applications and insights will emerge, further solidifying its importance in the field.

• 762229-49-2(2,6-difluoro-benzamidine)
• 764648-43-3(2,4,5-Trifluorobenzamidine hydrochloride)
• 885957-28-8(2,5-Difluoro-benzamidine)
• 57075-81-7(2-fluorobenzene-1-carboximidamide hydrochloride)
• 304867-43-4(2,6-Difluorobenzenecarboximidamide Hydrochloride)
• 175277-88-0(3-Fluoro-4-methylbenzenecarboximidamidehydrochloride)
• 785754-37-2(3-fluoro-4-methylbenzene-1-carboximidamide)
• 885957-21-1(2,4-difluoro-benzamidine)
• 885957-09-5(2,3-difluorobenzene-1-carboximidamide)
• 556814-98-3( )